Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 1
1974 1
1975 2
1977 2
1978 1
1979 5
1980 4
1981 3
1982 7
1983 3
1984 2
1985 7
1986 8
1987 10
1988 5
1989 7
1990 10
1991 7
1992 14
1993 16
1994 15
1995 15
1996 18
1997 6
1998 4
1999 4
2000 10
2001 10
2002 8
2003 11
2004 4
2005 10
2006 9
2007 5
2008 11
2009 8
2010 14
2011 7
2012 7
2013 5
2014 6
2015 3
2016 7
2017 5
2018 3
2019 7
2020 1
2021 3
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

320 results

Results by year

Filters applied: . Clear all
Page 1
Ibrutinib and Venetoclax for First-Line Treatment of CLL.
Jain N, Keating M, Thompson P, Ferrajoli A, Burger J, Borthakur G, Takahashi K, Estrov Z, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Sasaki K, Kanagal-Shamanna R, Patel K, Jorgensen J, Garg N, Wang X, Sondermann K, Cruz N, Wei C, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda W. Jain N, et al. Among authors: plunkett w. N Engl J Med. 2019 May 30;380(22):2095-2103. doi: 10.1056/NEJMoa1900574. N Engl J Med. 2019. PMID: 31141631 Clinical Trial.
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia: A Nonrandomized Phase 2 Trial.
Jain N, Keating M, Thompson P, Ferrajoli A, Burger JA, Borthakur G, Takahashi K, Estrov Z, Sasaki K, Fowler N, Kadia T, Konopleva M, Alvarado Y, Yilmaz M, DiNardo C, Bose P, Ohanian M, Pemmaraju N, Jabbour E, Kanagal-Shamanna R, Patel K, Wang W, Jorgensen J, Wang SA, Garg N, Wang X, Wei C, Cruz N, Ayala A, Plunkett W, Kantarjian H, Gandhi V, Wierda WG. Jain N, et al. Among authors: plunkett w. JAMA Oncol. 2021 Aug 1;7(8):1213-1219. doi: 10.1001/jamaoncol.2021.1649. JAMA Oncol. 2021. PMID: 34110383 Free PMC article. Clinical Trial.
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer.
Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, Honess D, Madhu B, Goldgraben MA, Caldwell ME, Allard D, Frese KK, Denicola G, Feig C, Combs C, Winter SP, Ireland-Zecchini H, Reichelt S, Howat WJ, Chang A, Dhara M, Wang L, Rückert F, Grützmann R, Pilarsky C, Izeradjene K, Hingorani SR, Huang P, Davies SE, Plunkett W, Egorin M, Hruban RH, Whitebread N, McGovern K, Adams J, Iacobuzio-Donahue C, Griffiths J, Tuveson DA. Olive KP, et al. Among authors: plunkett w. Science. 2009 Jun 12;324(5933):1457-61. doi: 10.1126/science.1171362. Epub 2009 May 21. Science. 2009. PMID: 19460966 Free PMC article.
Clofarabine in leukemia.
Ghanem H, Jabbour E, Faderl S, Ghandhi V, Plunkett W, Kantarjian H. Ghanem H, et al. Among authors: plunkett w. Expert Rev Hematol. 2010 Feb;3(1):15-22. doi: 10.1586/ehm.09.70. Expert Rev Hematol. 2010. PMID: 21082931 Review.
Sapacitabine for cancer.
Liu X, Kantarjian H, Plunkett W. Liu X, et al. Among authors: plunkett w. Expert Opin Investig Drugs. 2012 Apr;21(4):541-55. doi: 10.1517/13543784.2012.660249. Epub 2012 Feb 14. Expert Opin Investig Drugs. 2012. PMID: 22329458 Free PMC article. Review.
What does apoptosis mean in CLL?
Binet JL, Plunkett W, Robertson B, Merle-Beral H, Mentz F, Hoffbrand AV, Panayiotidis P. Binet JL, et al. Among authors: plunkett w. Leuk Lymphoma. 1996 Oct;22 Suppl 2:47-52. doi: 10.3109/10428199609102702. Leuk Lymphoma. 1996. PMID: 9021708 Review. No abstract available.
Preclinical characteristics of gemcitabine.
Plunkett W, Huang P, Gandhi V. Plunkett W, et al. Anticancer Drugs. 1995 Dec;6 Suppl 6:7-13. doi: 10.1097/00001813-199512006-00002. Anticancer Drugs. 1995. PMID: 8718419 Review.
Purine and pyrimidine nucleoside analogs.
Plunkett W, Gandhi V. Plunkett W, et al. Cancer Chemother Biol Response Modif. 2001;19:21-45. Cancer Chemother Biol Response Modif. 2001. PMID: 11686015 Review. No abstract available.
320 results